Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients

NCT06094387 is registered in ClinicalTrials.gov with Queen Mary Hospital, Hong Kong as lead sponsor.

NCT NCT06094387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06094387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients
Lead sponsor
Queen Mary Hospital, Hong Kong
Phase
Observational
Overall status
Terminated
Start date
April 6, 2024
Completion date
April 1, 2025
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central line complication, thrombosis, venous